285 related articles for article (PubMed ID: 26519026)
1. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
Abwainy A; Babiker F; Akhtar S; Benter IF
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H104-12. PubMed ID: 26519026
[TBL] [Abstract][Full Text] [Related]
2. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
3. Postconditioning of ischemic heart by intermittent ventricular pacing at the beginning of reperfusion: novel mechanisms and potential utilities in interventional cardiology settings.
Yang F; Xi L
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H1-3. PubMed ID: 26566731
[No Abstract] [Full Text] [Related]
4. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
Kaur K; Singh N; Dhawan RK
Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
[TBL] [Abstract][Full Text] [Related]
5. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
Salie R; Alsalhin AKH; Marais E; Lochner A
Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
[TBL] [Abstract][Full Text] [Related]
11. Effect of maturation on the resistance of rat hearts against ischemia. Study of potential molecular mechanisms.
Griecsová L; Farkašová V; Gáblovský I; Khandelwal VK; Bernátová I; Tatarková Z; Kaplan P; Ravingerová T
Physiol Res; 2015; 64(Suppl 5):S685-96. PubMed ID: 26674286
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury.
Khalaf A; Babiker F
J Physiol Biochem; 2016 Sep; 72(3):495-508. PubMed ID: 27325083
[TBL] [Abstract][Full Text] [Related]
13. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
16. The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.
Ferreira AJ; Jacoby BA; Araújo CA; Macedo FA; Silva GA; Almeida AP; Caliari MV; Santos RA
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1113-9. PubMed ID: 17056670
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Imamura H; Iwasaka T
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2473-9. PubMed ID: 18390819
[TBL] [Abstract][Full Text] [Related]
18. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart.
Pachauri P; Garabadu D; Goyal A; Upadhyay PK
Mol Cell Biochem; 2017 Jun; 430(1-2):99-113. PubMed ID: 28293875
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
